CD4 and cancer: This finding underlines the controversial role of CD4+ immune cells in cancer immune response: various subsets of CD4+ ICs can either suppress (T helper 2 CD4+ and T regulatory CD4+ cells) or promote (T helper 1 CD4+ cells and CD4+ cytotoxic lymphocytes) antitumor immunity modulating cytotoxic T cell responses [21].